Hepatitis C toolkit

People who inject drugs are a key population for the elimination of hepatitis C in Europe, and increasing their access to HCV testing and care is a goal in European and national hepatitis C policies. Despite this, HCV testing remains low among people who inject drugs and effective approaches to promote testing as the first element of a cascade of care are particularly needed.

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has launched a vital toolkit to enhance Hepatitis C testing and care, supporting the World Health Organisation’s 2030 goal to eliminate Hepatitis. It is a step by step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment for people who inject drugs. It incorporates tools and materials supporting the organisation of a participatory process for identifying actions at the national or local level in order to improve the situation.

The toolkit was presented at the World Hepatitis Summit held this week in Lisbon.

More information and the toolkit are available following this link>>>.

 

Hep C robust prevalence estimates

The European Centre for Disease Prevention and Control published their new Toolkit to support the generation of robust estimates of hepatitis C prevalence. This toolkit supports EU Member States in generating robust prevalence estimates for hepatitis C.

The overarching aim of this toolkit is to gain a better understanding of the HCV epidemiology in the EU/EEA.

European surveillance data show on-going transmission of viral hepatitis across the European Union and European Economic Area (EU/EEA). The available notification data however, do not provide a clear epidemiological picture of hepatitis C in Europe. Prevalence data from population surveys are a key source of information to complement the surveillance data for hepatitis C due to the limitations of surveillance for hepatitis: the infection is often asymptomatic and notifications are strongly influenced by local testing practices.

This toolkit offers:

  • An algorithm to assist EU/EEA Member States in their decision-making around selecting the type of HCV prevalence survey that should be undertaken
  • The technical protocol for conducting hepatitis C prevalence surveys in the general population
  • Modelled estimates of the national burden of viral hepatitis C in EU/EEA countries

To read and download the Protocol, follow this link>>>

UNODC launched toolkit on synthetic drugs

UNODC launched the United Nations Toolkit on Synthetic Drugs, a web-based platform with a wide range of electronic resources that offer innovative and practical tools on how to approach challenges related to synthetic drugs and particularly opioids.

The toolkit is part of UNODC’s Integrated Opioid Strategy that was launched last year to deal with the deadly opioid crisis. UNODC is the lead UN Secretariat entity in providing assistance to Member States in addressing the world drug problem and in collaboration with the World Health Organization (WHO), the International Narcotics Control Board (INCB) and other international and regional organizations is coordinating the development of this toolkit to support countries in addressing the threat of synthetic drugs.

The Toolkit offers a selection of different topics critical in addressing the key challenges presented by synthetic drugs. Generally, these topics range from legislative approaches, forensic capacity, prevention, treatment and rehabilitation, and access to medicines to regulation, detection and interdiction. Currently, three modules are complete and accessible: Legal, Forensics and Precursors. The remaining modules are in development and will become available soon. Moreover, the toolkit will be frequently updated and complemented with additional resources.

The toolkit was formally presented by Justice Tettey, Chief of UNODC’s Laboratory and Scientific Section, at a side event during the 62nd session of the Commission on Narcotic Drugs (CND), co-organized by the governments of Canada, Columbia and the United States of America.

Justice TetteyMr. Tettey, Chief of UNODC’s Laboratory and Scientific Section, underlined, “the toolkit has been developed in an interactive and user-friendly way for the benefit of Member States. You can have a toolkit in your pocket.”  The U.S. Head of Delegation to the CND’s 62nd Regular Session, Mr. James A. Walsh highlighted the fact that “as an online platform, the toolkit will serve as a self-assessment tool that allows countries to identify and address the specific synthetic drug challenges they are facing.”

Over the past 150 years, humanity has experienced several opioid crises, but none as devastating as the present one. Opioids remain one of the most important classes of medicines, providing essential pain relief and palliative care for many millions of people in need. But the deadly consequences of non-medical use pose some of the greatest drug challenges we face today.

The Toolkit is available following this link>>>